학술논문
Safety and immunogenicity of the FINLAY-FR-1A vaccine in COVID-19 convalescent participants: an open-label phase 2a and double-blind, randomised, placebo-controlled, phase 2b, seamless, clinical trial
Document Type
Article
Author
Ochoa-Azze, R.; Climent-Ruiz, Y.; Chiodo, F.; Rodríguez-Noda, L.; González-Mugica, R.; Valdés-Balbín, Y.; García-Rivera, D.; Verez-Bencomo, V.; Chang-Monteagudo, A.; Macías-Abraham, C.; de los Ángeles García-García, M.; Jerez-Barceló, Y.; Triana-Marrero, Y.; Ruiz-Villegas, L.; Dairon Rodríguez-Prieto, L.; Valenzuela-Silva, C.; Guerra-Chaviano, P.P.; Sánchez-Ramírez, B.; Hernández-García, T.; Orosa-Vázquez, I.; Díaz-Hernández, M.; Calcagno, A.; Ghisetti, V.; Rodríguez-Acosta, M.; Noa-Romero, E.; Enríquez-Puertas, J.; Ortega-León, D.; Valdivia-Álvarez, I.; Delahanty-Fernández, A.; Palenzuela-Díaz, A.
Source
In: The Lancet Respiratory Medicine . (The Lancet Respiratory Medicine, August 2022, 10(8):785-795)
Subject
Language
English
ISSN
22132619
22132600
22132600